EFM
PRME icon

E Fund Management’s Prime Medicine PRME Stock Holding History

E Fund Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.6K Sell
20,484
-6,615
-24% -$22K ﹤0.01% 480
2026
Q1 		$94.3K Buy
+27,099
New +$103K ﹤0.01% 472

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

E Fund Management's PRME Position: Q2 2026 in Review

E Fund Management reduced its Prime Medicine (PRME) stake by 24% in Q2 2026, selling an estimated $22K and leaving 20,484 shares worth $75.6K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

E Fund Management first reported a position in PRME in Q1 2026 and has held it in 2 quarters since. The position peaked at $94.3K in Q1 2026. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • E Fund Management held 20,484 shares of Prime Medicine worth $75.6K as of Q2 2026.
  • E Fund Management sold 6,615 Prime Medicine shares in Q2 2026, an estimated $22K.
  • Prime Medicine made up ﹤0.01% of E Fund Management's portfolio in Q2 2026, its #480 holding.
  • E Fund Management first reported a position in Prime Medicine in Q1 2026 and has held it in 2 quarters since.
  • E Fund Management's Prime Medicine position peaked at $94.3K in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.